Adapt Plus 2.0
Natural health product licensed in Canada
- Licence holder
- 9474-8233 Quebec Inc.
- NPN or DIN-HM
- 80127642
- Status
- Active licence
- Licence date
- 30 October 2023
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 200 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 2,160 mg | 180 mg | Not calculated |
| Ocimum tenuiflorum Source : Ocimum tenuiflorum - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,500 mg | 250 mg | Not calculated |
| Panax quinquefolius Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 600 mg | 150 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 100 mg | 200,000 µg |
| Riboflavine Source : Riboflavine 5'-phosphate | 5 mg | 10,000 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 50 mg | 100,000 µg |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 12.5 mg | 25,000 µg |
Non-medicinal ingredients
Gélatine, Poudre d'enveloppes d'Oryza sativa (Riz)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism/(and) tissue formation. Helps to form red blood cells. Helps to maintain/support immune function/the immune system. Helps to maintain/support the body¿s ability to metabolize nutrients. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Panax quinquefolius is traditionally used in Herbal Medicine to help relieve restlessness and/or nervousness (nervine/calmative). Withania somnifera is traditionally used in Ayurveda for memory enhancement. Withania somnifera is traditionally used in Ayurveda to balance aggravated Vata nervine. Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80127642
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.